跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8 条关于
“Recludix”
全部
8
临床试验
0
药物
1
机构
0
资讯
7
去年
Recludix Unveils First-in-Class BTK SH2 Domain Inhibitor with Superior Selectivity for Chronic Spontaneous Urticaria
去年
Recludix's STAT6 Inhibitor Shows Promising Efficacy in Preclinical Asthma Model, Matching Biologic Treatments
9个月前
Recludix Pharma Receives FDA Clearance for First-in-Class Oral STAT6 Inhibitor REX-8756 to Enter Phase 1 Testing
4个月前
Recludix's Oral STAT6 Inhibitor REX-8756 Shows Efficacy Comparable to Monoclonal Antibodies in Atopic Dermatitis Model
去年
Agomab Therapeutics Secures $89 Million to Advance Fibrotic Disease Treatments
10个月前
STAT Inhibitor Pipeline Expands with 22 Drugs Across 18 Companies Targeting Cancer and Inflammatory Diseases
3个月前
Corrixr Therapeutics Names Seagen Veteran Nancy Whiting as Board Chair Ahead of CRISPR Oncology Push